Apellis Pharmaceuticals (APLS) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Apellis Pharmaceuticals (APLS) over the last 6 years, with Q3 2025 value amounting to -$19.7 million.
- Apellis Pharmaceuticals' Other Gross PP&E Adjustments fell 1559.2% to -$19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.7 million, marking a year-over-year decrease of 1559.2%. This contributed to the annual value of -$54.6 million for FY2024, which is 1262.98% down from last year.
- As of Q3 2025, Apellis Pharmaceuticals' Other Gross PP&E Adjustments stood at -$19.7 million, which was down 1559.2% from -$14.6 million recorded in Q2 2025.
- In the past 5 years, Apellis Pharmaceuticals' Other Gross PP&E Adjustments registered a high of -$14.6 million during Q2 2025, and its lowest value of -$54.6 million during Q4 2024.
- In the last 5 years, Apellis Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$19.7 million in 2025 and averaged -$24.6 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first tumbled by 6929.55% in 2021, then skyrocketed by 2068.44% in 2023.
- Quarter analysis of 5 years shows Apellis Pharmaceuticals' Other Gross PP&E Adjustments stood at -$42.3 million in 2021, then fell by 14.45% to -$48.4 million in 2022, then dropped by 0.08% to -$48.5 million in 2023, then dropped by 12.63% to -$54.6 million in 2024, then surged by 63.87% to -$19.7 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$19.7 million for Q3 2025, versus -$14.6 million for Q2 2025 and -$15.3 million for Q1 2025.